Summary of NICE guidance on treatment of type 2 diabetes.
Qtern contains a fixed-dose combination of saxagliptin and dapagliflozin for use in type II diabetes inadequately controlled by metformin and/or a sulfonylurea plus saxagliptin or dapagliflozin.
Metformin-containing products can now be used in patients with moderate renal impairment following a review of the evidence by the European Medicines Agency (EMA).
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.